Lodosyn

Carbidopa An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself.

Molecular Formula: C₁₀H₁₆N₂O₅

InChI: InChI=1/C10H14N2O4.H2O/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6;/h2-4,12-14H,5,11H2,1H3,(H,15,16);1H2/f/h15H;

InChIKey: InChIKey=QTAOMKOIBXZKND-PGMRYZJXCQ
SMILES: CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.O

Names:
    Carbidopa (JP15/USP)
    carbidopa
    D00558
    Lodosyn (TN)
    Lodosyn
    3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methyl-propanoic acid hydrate
    38821-49-7

Registries:
    PubChem CID 441291
    PubChem ID 7847624